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Abstract
Background: Concordance is characterised as a negotiation-like health communication approach based on an
equal and collaborative partnership between patients and health professionals. The Leeds Attitudes to Concordance
II (LATCon II) scale was developed to measure the attitudes towards concordance. The purpose of this study was to
translate the LATCon II into Chinese and psychometrically test the Chinese version of LATCon II (C-LATCon II).
Methods: The study involved three phases: i) translation and cross-cultural adaptation; ii) pilot study; and iii) a
cross-sectional survey (n = 366). Systematic random sampling was used to recruit hypertensive patients from nine
communities covering around 78,000 residents in China. Tests of psychometric properties included content validity,
construct validity, criteria-related validity (correlation between the C-LATCon II and the Therapeutic Adherence Scale
for Hypertensive Patients (TASHP)), internal reliability, and test-retest reliability (n = 30).
Results: The study found that the C-LATCon II had a satisfactory content validity (item-level Content Validity Index
(CVI) = 0.83-1, scale-level CVI/universal agreement = 0.89, and scale-level CVI/averaging calculation = 0.98), construct
validity (four components extracted explained 56.66 % of the total variance), internal reliability (Cronbach’s alpha of
overall scale and four components was 0.78 and 0.66-0.84, respectively), and test-retest reliability (Pearson’s
correlation coefficient = 0.82, p < 0.001; interclass correlation coefficient = 0.82, p < 0.001; linear weighted kappa
statistic for each item = 0.40-0.65, p < 0.05). Criteria-related validity showed a weak association (Pearson’s correlation
coefficient = 0.11, p < 0.05) between patients’ attitudes towards concordance during health communication and
their health behaviours for hypertension management.
Conclusions: The C-LATCon II is a validated and reliable instrument which can be used to evaluate the attitudes to
concordance in Chinese populations. Four components (health professionals’ attitudes, partnership between two
parties, therapeutic decision making, and patients’ involvement) describe the attitudes towards concordance during
health communication.
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Background
The concept of concordance originates from a focus on
a medical problem: “Why do patients not follow the
treatment, as directed?” One of the primary reasons is
that during health communication, the treatment regi-
mens that are decided by health professionals might not
be feasible or acceptable to patients. This mismatch
between agreement calls for a shift of focus in health
promotion from merely evaluating patients’ individual
health behaviours to focusing on the earlier stage – asses-
sing health communication between patients and health
professionals.
The publication of the concordance report [1] signals
a new way of thinking about health communication.
Concordance is characterised as a negotiation-like health
communication approach based on an equal partnership
between patients and health professionals, collaborative
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attitude in therapeutic decision-making, and sufficient
consideration of the patients’ preferences [2–4]. Con-
cordant health communication seeks to improve the
trust between patients and health professionals involved
and the acceptability and feasibility of the treatment reg-
imens, which are then likely to contribute to the level of
adherence to treatment regimens [5, 6].
Raynor et al., [7] developed a 12-item Leeds Attitudes to
Concordance (LATCon) scale for measuring the attitudes
towards concordance during health communication. It has
been used in several studies by recruiting health profes-
sionals [7], patients [8], medical students [9], and pharma-
cists [10]. Knapp et al., [11] subsequently modified the
LATCon and developed a 20-item (Leeds Attitudes to Con-
cordance scale II (LATCon II). The LATCon II has been
used in three studies to assess health professionals’ attitudes
towards concordance [11–13].
So far, the LATCon has been translated into Finnish [10]
and the LATCon II has been translated into Spanish [12].
Following permission of the LATCon II authors, this study
sought to translate the LATCon II into Chinese and exam-
ine the psychometric properties in a Chinese population.
Methods
Design
This study comprised three stages: 1) structural process
to translate the original English version of LATCon II
into the target Chinese version of LATCon II; 2) pilot
study to evaluate the participants’ understanding of the
translated LATCon II; and 3) primary cross-sectional
survey to test the psychometric properties of the trans-
lated LATCon II.
Sample and settings
This study recruited hypertensive patients as the partici-
pants for two reasons. First, patients with chronic dis-
eases are often in the best position to know what is
required to manage their health on a daily basis. So, the
concept of concordance aligns better within chronic
health condition prevention and management settings
[5, 14]. Second, hypertension is a chronic disease, which
requires lifelong treatment. The inclusion criteria for
recruiting participants included: 1) diagnosis of primary
hypertension, 2) ≥ 18 years of age, 3) have been provided
with treatment regimens for hypertension management
(i.e. medication therapy and lifestyle modifications), and
4) willing to participate in the study. The exclusion cri-
teria were: 1) secondary hypertension, 2) patients with
severe complications of hypertension (e.g. stroke and
severe heart failure), and 3) patients who were cogni-
tively impaired.
Participants were recruited from nine Community
Health Centres (CHCs) in Nantong City, China. Nantong
City has a population of 7.6 million [15], and the nine
CHCs targeted covers around 78,000 residents. While the
overall prevalence of hypertension in China was estimated
to be 18.8 % [16], the prevalence of hypertension in Nan-
tong City was 21.61 % in 2013 [17]. CHCs have been estab-
lished in China to provide disease prevention and control,
healthcare services, health education, family planning, med-
ical treatment services, and community rehabilitation [18].
Electronic Health Records (EHRs) are used in CHCs for re-
cording health prevention and treatment plans for resi-
dents. In this study, EHRs assisted with identifying the
potential participants who attended the CHCs.
The sample size for testing psychometric properties is
recommended to be at least 10 times the number of the
items in an instrument [19]. As a result, the minimum
sample required for this study was 200 (20 items in the
original LATCon II). We planned to recruit 300 partici-
pants in this study. Considering a possible non-response
rate of 25 %, we aimed to recruit 400 (300/75 %) poten-
tial participants. At the beginning of the data collection,
3,287 hypertensive patients were available in the EHRs,
and we then used systematic random sampling to target
every 8th (3,287/400) patient from the EHR list.
Instruments
The LATCon II [11] is a 20-item scale measured using a
4-point Likert scale: strongly disagree (0), disagree (1),
agree (2), and strongly agree (3). Five items (i.e. Items 11,
14, 15, 18, and 20) in the original English LATCon II were
reversed scored, and overall the original English instru-
ment had satisfactory psychometric properties: test-retest
reliability (Pearson’s correlation coefficient = 0.64), internal
consistency reliability (Cronbach’s α = 0.82), and construct
validity [11]. Exploratory factor analysis (EFA) identified
five components, which explained 54 % of the overall vari-
ance. The components were: 1) level of participation and
involvement that the respondents feel patients’ should
have within the consultation; 2) continued use of a pater-
nalistic style of interaction; 3) necessity to find common
ground and be in agreement over decisions; 4) perceived
benefits of partnership in medicine taking; and 5) equality
and shared control within the interaction. By translating
the LATCon II into Chinese language will enable the atti-
tudes towards concordance during health communication
to be measured in Chinese speaking patients.
This study used the 25-item 5-point Likert Therapeutic
Adherence Scale for Hypertensive Patients (TASHP) [20]
to measure the level of adherence to treatment to test the
criteria-related validity. This instrument was already avail-
able in Chinese language. The TASHP measures patients’
health behaviours required to manage hypertension,
whereas the LATCon II measures their attitudes. In this
study the criteria-related validity was based on the theor-
etical linkage between health communication and health
behaviours [21, 22].
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Data collection
Data were collected between March and August 2013.
Stage 1: translation process
The process for translating the LATCon II from Eng-
lish into Chinese followed Sousa’s guidelines of trans-
lation, adaptation and validation of instruments [19]
and is summarised in Fig. 1. The translation technique
contained five steps: 1) A forward translation was con-
ducted by two independent translators with distinct
backgrounds from source language (English) to target
language (Chinese); 2) A third independent translator
initially compared the two forward-translated versions
of the LATCon II with the original version of the LAT-
Con II regarding ambiguities and discrepancies of
words, sentences and meanings. The second step gen-
erated a preliminary initial translated version of the
LATCon II in Chinese; 3) The initial Chinese version
of the LATCon II was translated back into English by
two other independent translators with the same qual-
ifications and characteristics, described above in step
one. These two translators were blind to the original
English version of the LATCon II. This process
resulted in two back-translated versions of the LAT-
Con II in English; 4) A multi-disciplinary committee
was established by the above five translators to discuss
the ambiguities and discrepancies between the two
back-translations and between each one of the two
back-translations and the original LATCon II in Eng-
lish. The developer of the original English LATCon II
was invited to resolve any confusion on the meaning
of the items. This step established content equivalence
between English and Chinese versions of the LATCon
II to generate the pre-final Chinese version of the
LATCon II; and 5). An expert panel with six members
were invited to conduct cross-cultural adaptation for
the pre-final version.
The selection criteria of five translators were: 1) fluent
in English and experienced in translation; 2) holding the
title of Associate Professor or Co-Chief nurse or higher;
and 3) with educational background of master’s degree
or higher. The selection criteria of six expert panel
members were: 1) experienced in health communication
during nursing practice; 2) holding the title of Associate
Professor or Co-Chief Nurse or higher; 3) with educa-
tional background of Master’s Degree or higher; and 4)
specialised in psychometric evaluation.
Stage 2: pilot study
The pre-final version of the instrument was pilot tested
among Chinese hypertensive patients to evaluate the
instructions, response format and the items of the LAT-
Con II for clarity. Using convenience sampling from
the patients at the CHCs, fifteen participants were in-
vited to rate the instructions and items of the LATCon
II using a dichotomous scale (clear or unclear). Any
participants who rated the instructions, response for-
mat or any item of the LATCon II as unclear were
asked to provide suggestions on the modification. The
Chinese version of the LATCon II (C-LATCon II) scale
was then finalised. Then, the six-member expert panel
was invited to evaluate each item of the instrument for
Fig. 1 Translation process
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content equivalence using the following scale: 1 = not
relevant; 2 = unable to assess relevance; 3 = relevant but
needs minor alteration; 4 = very relevant and succinct.
Stage 3: primary cross-sectional survey
Following training by the first author, five CHC health
professionals recruited potential participants through
initial telephone contact using a standard script to avoid
perceived coercion. A random sample of interview was
selected to monitor adherence to study protocol and to
ensure fidelity. The patients who agreed to participate in
this study were then invited to come to the CHCs for a
routine health appointment. The rationale for this proced-
ure was that patients were familiar with and trusted the
CHC health professionals who were responsible for their
healthcare. After telephone recruitment, further and
detailed explanation was provided by the first author at the
CHC. Participants then provided voluntary consent before
completing the C-LATCon II and the TASHP. In addition,
30 participants were invited to complete the C-LATCon II
14 days (time 2) after their first participation (time 1). The
scales were checked for any missing data after the partici-
pants’ completion when they submitted to investigators.
Once missing data were found, the scales were given back
to the participants to complete.
Data analysis
In the pilot study, first, the interrater agreement (IR)
among patients was calculated to evaluate the level of their
understanding of the C-LATCon II. Then, IR among expert
panel members was calculated to reflect their proportion of
agreement on evaluating the C-LATCon II [23]. After that,
content validity of the C-LATCon II was tested by measur-
ing the content validity index (CVI), including item-level
CVI (I-CVI) and scale-level CVI (S-CVI). S-CVI includes
S-CVI/UA (universal agreement) and S-CVI/Ave (aver-
aging calculation). Modified kappa statistic (k*) was used to
examine the agreement on each item which was rated ≥ 3
by the expert panel members. The criteria for a satisfactory
CVI used in this study were: IR ≥ 0.8; I-CVI ≥ 0.83; k* ≥
0.74; S-CVI/UA ≥ 0.8; and S-CVI/Ave ≥ 0.9 [24, 25].
In the primary cross-sectional survey, participants who
did not complete half of the items in the three scales
were deleted from the raw data. Little’s Missing Com-
pletely at Random (MCAR) Test was used to evaluate
whether the continuous data were missed randomly; re-
vealed a p value > 0.05 indicating that data were missed
in a random way. Expectation Maximization (EM) was
used to impute missing continuous data. Mode substitu-
tion was used to impute missing categorical data.
Data were analysed using Statistical Package for Social
Sciences (SPSS) 21.0 for Windows. Construct validity
was tested by conducting EFA. Criteria-related validity
was tested by measuring Pearson’s correlation between
the C-LATCon II and the TASHP. Internal consistency
was tested by calculating Cronbach’s α. Test-retest reli-
ability was calculated by Pearson’ correlation coefficient
and intraclass correlation coefficient (ICC) between time
1 and time 2, and by linear weighted Cohen’s kappa stat-
istic for each item. Two-sided p < 0.05 was considered
statistically significant.
Ethical considerations
Permission was requested from participants and the man-
ager in charge of the CHCs selected. Approvals were
received from Nantong University Affiliated Hospital Ethics
Committee [2012(030)] and Queensland University of
Technology Ethics Committee (1300000022).
Results
Stage 1: translation process
To make the questions in the LATCon II contextually
suitable for Chinese hypertensive patients, three changes
were made after translation and before the pilot study
was conducted. First, all of the words “patients” in the
original 20-item LATCon II were replaced with “me”.
Second, in the 5th step of the instrument translation
process, the expert panel recommended deleting Item
19: “During the doctor-patient consultation my decision
is the most important” and Item 20: “I should be able to
take on as much responsibility as I wish for my own
treatment” due to the highly likely confusion and misun-
derstanding among the target (Chinese) population. This
change yielded a total number of 18 items in the pre-
final C-LATCon II. The two deleted items were also
translated in the pilot study to seek participants’ under-
standing of and suggestion regarding these items. Third,
“medicine” in three items of the original LATCon II
were changed into “treatment” for the following two rea-
sons: 1) “the benefits of the medicine” in Item 8, “medi-
cine taking” in Item 13, and “patients’ views about
medicines” in Item 14 refer to only medication therapy
in Chinese language, while hypertension management
includes not only medication therapy but also lifestyle
modifications; and 2) similarly, “treatment” indicates
both medication therapy and lifestyle modifications pre-
scribed by health professionals.
Stage 2: pilot study
The IR for the 18-item pre-final C-LATCon II was 100 %,
which indicated that all participants (n = 15) clearly under-
stood all 18 items of the pre-final C-LATCon II. Partici-
pants also expressed their confusion about the two
deleted items. There were three primary reasons for their
confusion: 1) they felt unclear about what kind of “deci-
sion” Item 19 refers to; 2) they felt confused about Item
19 because they thought that they would have not con-
sulted doctors if their decision were the most important;
He et al. BMC Medical Informatics and Decision Making  (2015) 15:60 Page 4 of 10
and 3) they simply did not understand what Item 20
meant. As a result, Item 19 and Item 20 were removed
prior to testing the psychometric properties. The C-
LATCon II was then finalised and ready for psychometric
testing. An additional file shows the C-LATCon II in more
detail [see Additional file 1].
Before measuring CVI, the IR among expert panel mem-
bers of 0.89 indicated a good proportion of agreement on
evaluating the C-LATCon II [23]. I-CVI was 0.83-1. k* was
0.81-1. S-CVI/UA was 0.89. S-CVI/Ave was 0.98. All con-
tent validity indices showed that the C-LATCon II had a
satisfactory content validity.
Stage 3: primary cross-sectional survey
Of all the 411 (3287/8) potential participants contacted by
telephone, eight cases were excluded (not meeting inclusion
criteria), 21 cases did not respond, and 382 cases agreed to
participate at the CHCs. After telephone recruitment, 13
cases did not attend their appointments at the CHCs, and
369 participants completed the demographic characteris-
tics, C-LATCon II and TASHP. The data for three partici-
pants were deleted because they had completed less than
half of the items of the instruments, yielding a final total
number of 366 participants. No missing data were found in
the items of the C-LATCon II and the TASHP.
Descriptive analysis of demographic characteristics and the
C-LATCon II
The participants recruited in this study were on average
67 years of age. The number of males (n = 186) was
almost equal to that of females (n = 180). Most of the
participants were married (90.2 %). The demographic
characteristics are summarised in Table 1. The total pos-
sible score of the C-LATCon II was 54. In this sample,
the mean and standard deviation (SD) were 38.83 ± 4.72.
Construct validity
Six assumptions for EFA were tested before conduct-
ing EFA [26]. First, multivariate outliers (n = 13) were
detected and then deleted by calculating Mahalanobis
distance and using the criterion of α = 0.001 with 18 df
(the critical χ2 = 42.31). Second, the finalised sample
size of 353 (366–13) in this study was sufficient to
conduct EFA for the 18-item C-LATCon II. A suffi-
cient sample size minimises the probability of errors
and maximises the accuracy of population estimates.
Third, multicollinearity and singularity were tested by cal-
culating tolerance value and variance inflation factor (VIF).
The tolerance values were between 0.31 − 0.76. The VIF
values were between 1.32 − 3.22 (<5.0). So, the assumption
of absence of multicollinearity and singularity held. Fourth,
the Shapiro-Wilk normality test showed that none of the
C-LATCon II items were normally distributed (p < 0.05).
When examining the raw data, most participants scored 2
or 3 points in the items of this 4-point (from 0 to 3 points)
Likert scale. The Shapiro-Wilk normality test is not
appropriate to test the normality of Likert items when
participants seldom score items at either end of the
scale. However, the skewness and kurtosis values of all
18 items varied between −0.33 − 0.33 and −1.78 − 0.63
respectively which indicated that normality was not a
severe issue. Even so, Principal Components Analysis
(PCA) was chosen to extract components in this study
because PCA is robust on non-normality data. Fifth,
linearity among pairs of variables was assessed through
measurement of correlation. It was impractical to examine
all pairwise correlation to test linearity for all 18 items. So,
this study chose to test the correlation between the item
with the strongest positive skewness (0.33) and the item
with the strongest negative skewness (−0.33) because the
linearity between two opposite extreme items was ex-
pected to be among the worst. The Pearson’s correlation
coefficient was 0.34 (p < 0.001). This result indicated that
there was no evidence of true curvilinearity. Sixth, the
Kaiser-Meyer-Olkin (KMO) Measure of Sampling Ad-
equacy value of 0.84 (>0.6) and Bartlett’s Test of Sphericity
Table 1 Demographic and socioeconomic characteristics
(n = 366)
Characteristics No. of Missing
data (%)
Mean ± SD or
Frequency (%)








Primary school or lower 63 (17.2)














1 – 9 132 (36.1)
10 – 19 135 (36.9)
≥20 78 (21.3)
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(χ2 (153) = 2213.83, p < 0.001) indicated that the data were
suitable for EFA.
The number of components was determined by combin-
ing three criteria: Cattell’s scree test, Kaiser’s eigenvalue-
greater-than-one rule, and Horn’s parallel analysis [27].
The scree plot indicates that a sharp drop in the plot
occurred between the third and fourth lines and therefore
suggested a four-component extraction (Fig. 2). Four com-
ponents had eigenvalues ≥ 1, which suggested that the
number of components extracted was four (Table 2).
According to the output of Monte Carlo PCA for parallel
analysis, the Component 3 was considered significant
because the eigenvalue (1.53) of the Component 3 was
bigger than the 3rd random eigenvalue (1.27), whilst the
Component 4 was considered insignificant because the
eigenvalue (1.00) of the Component 4 was smaller than
the 4th random eigenvalue (1.22) (Table 2). Although the
scree plot, eigenvalue rule and parallel analysis provided
inconsistent results of the number of components to be
extracted, four components were identified after consider-
ing that the components extracted should reasonably
interpret the items. These components accounted for
more than 56 % of the total variance (Table 2).
Factor rotation was conducted for further interpret-
ation. Direct oblimin rotation was chosen because cor-
relation was assumed between the extracted components
in the C-LATCon II. Table 2 shows the four components
extracted and the factor loading of each item. The four
components were defined as: 1) health professionals’
attitudes; 2) partnership between two parties; 3) thera-
peutic decision making; and 4) patients’ involvement.
Criteria-related validity
Normality of the two scales was measured before cal-
culating Pearson’s correlation coefficient between the
C-LATCon II and the TASHP. According to the
Shapiro-Wilk test, both scales were not normally dis-
tributed (p < 0.05). Because the Shapiro-Wilk test may
be statistically significant from a normal distribution in
large samples [28], graphic distribution was required
for verification. According to the histograms, the two
scales were roughly bell shaped. So, there was no
severe problem of normal distribution in the two
scales. Although the Pearson’s correlation coefficient
was 0.11 and statistically significant (p < 0.05), the small
value of the Pearson’s correlation coefficient showed
that in this study sample the direct association between
patients’ attitudes towards concordance during health
communication and their health behaviour was weak.
Internal reliability
The value of Cronbach’s α of overall scale was 0.78, indi-
cating that the C-LATCon II had good internal reliability
(Table 2). The component “partnership between two
parties” had the lowest Cronbach’s α at 0.66 which is close
to 0.7 and was therefore acceptable. The Cronbach’s α of
the other three components were over 0.7, showing satis-
factory internal reliability [29].
Test-retest reliability
Thirty participants completed the C-LATCon II at time
1 and time 2 (14 days after time 1). Shapiro-Wilk’s
normality test of the overall C-LATCon II at time 1
(p > 0.05) and time 2 (p > 0.05) indicated a normal dis-
tribution at both times. Pearson’s correlation coefficient
of 0.82 (p < 0.001) and ICC (one-way random, single mea-
sures) of 0.82 (p < 0.001) indicated a statistically significant
and positive association of the total C-LATCon II scores
between time 1 and time 2 (Fig. 3). The values of linear
weighted kappa statistic for each item of the C-
LATCon II varied between 0.40-0.65 (p < 0.05), which
indicated that there was a mostly moderate agreement
(0.41-0.60 = moderate; 0.61-0.80 = substantial) for each
item at the different time points [30]. Because the C-
LATCon II is a self-reported instrument with four re-
sponse options for each item, the results of linear
weighted kappa statistic showed some variation in re-
sponses for each item at different time points. How-
ever, the results of Pearson’s correlation coefficient
and ICC suggested a satisfactory test-retest reliability
of the C-LATCon II.
Discussion
This study translated the C-LATCon II, and reported
satisfactory psychometric properties of the scale by
measuring content validity, construct validity, internal
reliability, and test-retest reliability. This study revealed
that the C-LATCon II appeared to be a reliable and
validated instrument, which can be used to measure
patients’ attitudes towards concordance during health
Fig. 2 Scree test
He et al. BMC Medical Informatics and Decision Making  (2015) 15:60 Page 6 of 10
communication in Chinese population. This study was
unique in three characteristics. First, the translation
process from the original English version of LATCon II
to the target Chinese version of LATCon II rigorously
followed Sousa’s guidelines to ensure that equivalence
between the two versions was established. Second, a
systematic random sampling was used to recruit partici-
pants. The purposes for this sampling strategy were to
assist with both the representativeness of the sample and
the generalisation of the results to a Chinese population.
Third, this study for the first time tested content validity
and criteria-related validity of the concordance instru-
ment. It should be noted that the test of criteria-related
validity showed that patients’ attitudes towards concord-
ance during health communication might not be an in-
dependent factor influencing their health behaviours.
Other factors (e.g. knowledge of hypertension manage-
ment and self-efficacy of hypertension management)
ought to be considered when testing the association be-
tween patients’ attitudes towards concordance during
health communication and their health behaviours in
future research.
Table 2 Means, SDs, factor loadings, and communalities of C-LATCon II (loadings ≥ 0.35 are shown, n = 353)
Factors Item Item content Mean
(SD)
C1 C2 C3 C4 h2
Health professionals’
attitude
1 Prescribing should take account of my expectations of treatment 2.26
(0.56)
0.72 0.54
5 Doctors should try to help me to make as informed a choice as possible about









8 Doctors should make clear when the benefits of the treatment are uncertain 2.43
(0.50)
0.46 0.45
9 Doctors should be more sensitive to how I react to the information they give 2.40
(0.50)
0.50 0.46





13 Doctors should encourage me to express my concerns about treatment 2.34
(0.54)
0.74 0.56





12 The doctor and I should find common ground on what the problem is and




15 The doctor is the expert and my role is to do as the doctor says 1.11
(0.73)
0.75 0.68







2 Doctors and I should agree a treatment plan that takes account of both views 2.40
(0.51)
−0.79 0.68












3 My involvement in the prescribing process always leads to better outcomes 2.32
(0.57)
0.36 0.41
4 The best use of treatments is when it is what I want and am able to achieve 2.39
(0.55)
0.47 0.45










Eigenvalue 5.59 2.10 1.53 1.00
Percentage of variance explained (%) (cumulative 56.66) 31.04 11.66 8.48 5.48
Cronbach’s α (total 0.78) 0.84 0.66 0.78 0.78
Items 11, 14, 15, and 18 are reversely scored. C 1–4 = Component 1–4. h2 = communality
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A four-component structure was identified from the
C-LATCon II. These components were consistent with
Horne and Weinman’s three-phase (input factors,
process of health communication, and outcome of
health communication) framework of concordance dur-
ing health communication [31]. The component health
professionals’ attitude described patients’ expectation of
health professionals’ attitudes towards health communi-
cation. The component patients’ involvement referred
to patients’ attitudes towards their involvement in
health communication. Both the first two components
reflected the patients’ perception of the attitudes from
two parties before commencement of health communi-
cation, and therefore belonged to input factors. The
third component partnership between two parties de-
scribed how patients perceived the relationship between
two parties during the encounter, and therefore revealed
how patients looked at the process of health communica-
tion. The fourth component therapeutic decision making
described the patients’ attitudes towards the roles played
by both parties when deciding treatment regimens, and
demonstrated the outcome of health communication. So,
these four components accurately measured patients’ atti-
tudes towards health communication at the three different
phases of Horne and Weinman’s framework.
The components extracted in this study were different
from the five components in the original UK study [11],
the three components in a Spanish study [12], and the
four components in a US study [13]. There are three
potential reasons for the difference of the components.
First, the different parties recruited might account for
differences in the components extracted. For example, in
the UK study, student nurses, medical students, and pre-
registration pharmacists at the same UK University were
recruited. The Spanish study recruited psychiatrists and
psychiatry registrars. The US study recruited students
enrolled in nursing, respiratory care and pharmacy. So,
these three studies recruited health professionals as the
participants. In contrast to the previous three studies,
this present study targeted patients instead of health
professionals as the participants.
The second reason is due to the different ethnic popu-
lations recruited in these studies. The three previous
studies recruited participants from UK, Spanish and US
populations, while the current study recruited Chinese
participants. No previous studies have been conducted
to investigate patients’ attitudes to concordance by using
the LATCon II, so it is not possible to compare the
influence of culture on patients’ attitudes to concordance
with other cultural populations. However, in the pilot
study, Chinese participants’ failure to understand two of
the translated items from the original English LATCon
II reflects the different perception of concordance be-
tween cultural groups.
Third, the deletion of two items from the original
LATCon II influenced the component extraction.
From a statistical perspective, a change in the number
of items in a scale will potentially change the number
of components and the items within components
extracted via EFA.
Patients with an expectation of a collaborative atti-
tude from health professionals and active involvement
in health communication tend to expect to negotiate
their healthcare as an equal (i.e. their input is valued by
health professionals). Surprisingly, this study found that
Chinese hypertensive patients scored the component
partnership between two parties much lower than the
other three components (health professionals’ attitude,
patients’ involvement, and therapeutic decision making).
That is, patients in this study tended to recognise an
unequal partnership with health professionals, but they
also expected at the same time a collaborative attitude
from health professionals and being involved in thera-
peutic decision making. There might be two reasons for
the perception of accepting an unequal partnership
with health professionals. First, health professionals’
traditional paternalistic attitudes to health communica-
tion makes Chinese patients believe that the partner-
ship is unequal [32, 33]. Second, the long-term unequal
partnership makes Chinese patients habitually believe
that health professionals should dominate the way
health communication occurs.
Limitation and future implications
This study recruited participants from nine CHCs, al-
though all CHCs came from one area in China due to
budgetary constraints. The systematic random sampling
Fig. 3 Scatter plot indicating total scale scores at time 1 and time
2 (n = 30)
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conducted in this study might have potential unknown
biases. A future multi-centre study should be conducted
by recruiting participants from more extensive regions
in China and using stratified random sampling. Further
research might be conducted to investigate the attitudes
towards concordance during health communication in
patients with other chronic diseases. The C-LATCon II
could be used to measure the effect of interventions
designed to improve patients’ attitudes towards concord-
ance during health communication in future research.
Nevertheless the rigour of the translation process and
testing procedures were a strength of this study.
Conclusion
The C-LATCon II is a validated and reliable instrument
which can be used to evaluate patients’ attitudes towards
concordance during health communication in Chinese
population. The four components (health professionals’
attitude, partnership between two parties, therapeutic
decision making and patients’ involvement) can be used to
describe patients’ attitudes towards concordance during
health communication.
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